Sign in
4/A

Changes in Ownership

Black Diamond Therapeutics, Inc. Filed Acc 0001415889-22-007101

Director acquired 4,946 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

DIXON WENDY L · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-06-17 Grant or award : show line 1 in the form +4,946 $2.03 $10,040 4,946 D
Loading xslF345X03/form4a-06302022_010603.xml…